Editorials

• A Decade of Experience With Transcatheter Aortic Valve Replacement: Now Is the Time to Resolve Doubts About Long-term Effectiveness

  Pilar Tornos, Aida Ribera

  Rev Esp Cardiol. 2017;70:234-5

• The Syndrome of Heart Failure With Preserved Systolic Function

  Chaudhry M.S. Sarwar, Javed Butler, Stefan D. Anker

  Rev Esp Cardiol. 2017;70:232-3

• Beyond Reperfusion Networks in ST-segment Elevation Myocardial Infarction: Assessment of Quality of Care

  François Schiele, Jean-Pierre Bassand

  Rev Esp Cardiol. 2017;70:140-1

• Should the Subcutaneous Implantable Defibrillator Be the First Choice for Primary Prevention of Sudden Cardiac Death?

  Reinoud E. Knops, Tom F. Brouwer

  Rev Esp Cardiol. 2017;70:142-4

• The Burgeoning Roots of Socioeconomic Inequalities in Health: The Legacy Effect

  David A. Alter, WeiYang Yu

  Rev Esp Cardiol. 2017;70:138-9

• Pregnancy and Cardiac Disease

  Jolien W. Roos-Hesselink, Joerg Ingolf Stein

  Rev Esp Cardiol. 2017;70:78-80

• “No Country for Old Men” With ST-segment Elevation Myocardial Infarction

  Manel Sabaté

  Rev Esp Cardiol. 2017;70:70-1

• Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias

  L. Pérez de IslaSEC Working Group for the 2016 ESC Guidelines for the Management of Dyslipidemias:Leopoldo Pérez de Isla, Pedro Luis Sánchez Fernández, Luis Álvarez-Sala Walther, Vivencio Barrios Alonso, Almudena Castro Conde, Enrique Galve Basilio, Luis García Ortiz, Pedro Mata LópezExpert Reviewers for the 2016 ESC Guidelines for the Management of Dyslipidemias:Eduardo Alegría Ezquerra, Alberto Cordero Fort, Juan Cosin Sales, Carlos Escobar Cervantes, Xavier García-Moll Marimón, Juan José Gómez Doblas, Domingo Marzal Martín, Nekane Murga Eizagaechevarria, Carmen de Pablo Zarzosa, Luis Miguel Rincón, Juan Sanchis ForésSEC Guidelines Committee:José Alberto San Román Calvar, Fernando Alfonso Manterola, Fernando Arribas Ynsaurriaga, Arturo Evangelista Masip, Ignacio Ferreira González, Manuel Jiménez Navarro, Francisco Marín Ortuño, Leopoldo Pérez de Isla, Luis Rodríguez Padial, Pedro Luis Sánchez Fernández, Alessandro Sionis Green, Rafael Vázquez García

  Rev Esp Cardiol. 2017;70:72-7

• Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation

  F. ArribasSEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:Fernando Arribas, Inmaculada Roldán, José Luis Merino, Vanessa Roldán, ÿngel Arenal, Juan Tamargo, Ricardo Ruiz-Granell, Lluís Mont, Manuel Anguita, Francisco MarínReviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:Vivencio Barrios Alonso, Gonzalo Barón, Esquivias, Juan Cosín Sales, Ernesto Díaz Infante, Carlos Escobar Cervantes, José Luis Ferreiro Gutiérrez, José M. Guerra Ramos, Francisco Javier Jiménez Candil, Nicasio Pérez Castellano, Antonia Sambola Ayala, Antonio Tello MontoliuSEC Guidelines Committee:Alberto San Román, Fernando Alfonso, Fernando Arribas, Arturo Evangelista, Ignacio Ferreira, Manuel Jiménez, Francisco Marín, Leopoldo Pérez de Isla, Luis Rodríguez Padial, Pedro L. Sánchez, Alessandro Sionis, Rafael Vázquez

  Rev Esp Cardiol. 2017;70:2-8

• Is Left Ventricular Endocardial Pacing the Future for Cardiac Resynchronization Therapy?

  John M. Morgan, Benedict M. Wiles

  Rev Esp Cardiol. 2017;70:14-5

• Start-up, Organization and Performance of a Multidisciplinary Pulmonary Embolism Response Team for the Diagnosis and Treatment of Acute Pulmonary Embolism

  David M. Dudzinski, James M. Horowitz

  Rev Esp Cardiol. 2017;70:9-13

• HIV and Heart Disease: What Cardiologists Should Know

  Franck Boccara, Ariel Cohen

  Rev Esp Cardiol. 2016;69:1126-30

• Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  A. SionisSEC Working Group for the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure:Alessandro Sionis Green, Nicolas Manito Lorite, Héctor Bueno, Antonio Coca Payeras, Beatriz Díaz Molina, José Ramón González Juanatey, Luis Miguel Ruilope Urioste, José Luis Zamorano GómezExpert Reviewers for the 2016 ESC Guidelines for the Treatment of Acute and Chronic Heart Failure:Luis Almenar Bonet, Albert Ariza Solé, Ramón Bover Freire, José Luis Lambert Rodríguez, Esteban López de Sá, Silvia López Fernández, Roberto Martín Asenjo, Sonia Mirabet Pérez, Domingo Pascual Figal, Javier Segovia Cubero, Alfonso Varela RománSEC Guidelines Committee:José Alberto San Román Calvar, Fernando Alfonso Manterola, Fernando Arribas Ynsaurriaga, Arturo Evangelista Masip, Ignacio Ferreira González, Manuel Jiménez Navarro, Francisco Marin Ortuño, Leopoldo Pérez de Isla, Luis Rodríguez Padial, Pedro Luis Sánchez Fernández, Alessandro Sionis Green, Rafael Vázquez García

  Rev Esp Cardiol. 2016;69:1119-25

• Will TAVI Be the Standard of Care in the Treatment of Aortic Stenosis?

  César Morís, Isaac Pascual, Pablo Avanzas

  Rev Esp Cardiol. 2016;69:1131-4

• New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has Begun

  Rafael Simó, Cristina Hernández

  Rev Esp Cardiol. 2016;69:1005-7

• Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity

  Mélanie Eyries, Florent Soubrier

  Rev Esp Cardiol. 2016;69:1003-4

• Reflections on the Importance of Frailty in the Assessment of Cardiovascular Risk in the Elderly

  Francesc Formiga, María Teresa Vidán, Albert Ariza-Solé, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2016;69:1008-10

• Dual Energy Coronary Computed Tomography Angiography for Detection and Quantification of Atherosclerotic Burden: Diagnostic and Prognostic Significance

  Daniele Andreini

  Rev Esp Cardiol. 2016;69:885-7

• Comments on the 2016 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice

  M.F. Jiménez Navarro

  Rev Esp Cardiol. 2016;69:894-9

• Should Embolic Protection Become the Standard of Care for Stroke Prevention During TAVI?

  Brandon M. Jones, Amar Krishnaswamy, Samir R. Kapadia

  Rev Esp Cardiol. 2016;69:890-3